Show simple item record

dc.contributor.authorAlhashmi, Ibrahim
dc.contributor.supervisorAssoc. Prof. Trilochan Mukkuren_US
dc.contributor.supervisorProf. John Wetherallen_US
dc.date.accessioned2017-04-11T03:47:29Z
dc.date.available2017-04-11T03:47:29Z
dc.date.issued2012
dc.identifier.urihttp://hdl.handle.net/20.500.11937/51705
dc.description.abstract

This thesis embodies research that has demonstrated that there is strong case for further development of novel live attenuated metabolite deficient B pertussis vaccine such that it is non-toxic because it polarises the immune response of DTaP-vaccinated mice from Th2 to Th1 following booster vaccination with the live attenuated vaccine thus offering the chance of long term protection against whooping cough and disrupting the transmission from adolescents and adults to infants.

en_US
dc.publisherCurtin Universityen_US
dc.titleLive Metabolite-Deficient Bordetella pertussis: Determination of Suitability for use as a Vaccine in Humans using the Pertussis Mouse Modelen_US
dc.typeThesisen_US
dcterms.educationLevelPhDen_US
curtin.departmentSchool of Biomedical Sciencesen_US
curtin.accessStatusOpen accessen_US
curtin.facultyHealth Sciencesen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record